acquired
Stage
2
Investors
About
Scale Biosciences develops single-cell sequencing technology that enables researchers to analyze millions of cells and multiplex hundreds of samples, providing unprecedented scale and flexibility in single-cell research.
Explore Scale Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.